WAM
GMAB icon

Wealthspire Advisors (Maryland)’s Genmab GMAB Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41,962
Closed -$1.42M – 516
2020
Q2 		$1.42M Buy
41,962
+10,513
+33% +$286K 0.1% 123
2020
Q1 		$666K Buy
31,449
+3,584
+13% +$79.9K 0.06% 198
2019
Q4 		$622K Sell
27,865
-488
-2% -$10.7K 0.04% 238
2019
Q3 		$574K Buy
+28,353
New +$558K 0.04% 236

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s GMAB Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) sold out of Genmab (GMAB) in Q3 2020, closing a stake of 41,962 shares — an estimated $1.42M sold.

Wealthspire Advisors (Maryland) first reported a position in GMAB in Q3 2019 and held it in 4 quarters. The position peaked at $1.42M in Q2 2020. 199 funds tracked by Wall St. Rank hold GMAB as of Q3 2020.

  • Wealthspire Advisors (Maryland) reported no remaining Genmab position as of Q3 2020 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 41,962 Genmab shares in Q3 2020, an estimated $1.42M.
  • Wealthspire Advisors (Maryland) first reported a position in Genmab in Q3 2019 and held it in 4 quarters.
  • Wealthspire Advisors (Maryland)'s Genmab position peaked at $1.42M in Q2 2020.
  • 199 funds tracked by Wall St. Rank held Genmab as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.